Biotech Investing

Person in blue scrubs interacts with a digital interface featuring graphs and medical icons.

Biotech and Pharma Market Trends: Q2 2026 Review and Forecast

Explore Q2 2026 biotech and pharma trends as AI reshapes drug discovery and investment dynamics.

Life Science Investing
Latest Articles

Top 5 Small-cap Biotech Stocks in 2026

Biotech Investing

Zymeworks Expands into Respiratory Market with Theravance Buyout

Life Science Investing

Nathan Moser: AI Hype Hiding Comeback in Small-cap Stocks

Life Science Investing

5 Biggest Biotechnology ETFs in 2026

Biotech Investing

5 Small-cap Biotech ETFs to Watch in 2026

Biotech Investing

Lu Zhang: Finding Strategic ROI in Physical AI and Vertical Healthcare

Artificial Intelligence Investing
Company Profiles
BCT:CC

BriaCell Therapeutics

Redefining Oncology with Personalized Cancer Immunotherapy

Biotech Investing
LEXX

Lexaria Bioscience

Drug delivery platform innovator with multiple mainstream applications

Biotech Investing
More Companies
biotech News
BriaCell Therapeutics (TSX:BCT)

BriaCell Opens First Canadian Site - Sunnybrook - for Pivotal Phase 3 Trial in Metastatic Breast Cancer

Pharmaceutical Investing
BriaCell Therapeutics (TSX:BCT)

BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT

Pharmaceutical Investing
BriaCell Therapeutics (TSX:BCT)

BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT

Pharmaceutical Investing
Lexaria Bioscience (NASDAQ:LEXX)

Lexaria Updates Business Development

Biotech Investing
Lexaria Bioscience (NASDAQ:LEXX)

Lexaria Updates Business Development

Biotech Investing
Lexaria Bioscience (NASDAQ:LEXX)

Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule

Biotech Investing
BriaCell Therapeutics (TSX:BCT)

BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT

Pharmaceutical Investing
Lexaria Bioscience (NASDAQ:LEXX)

Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule

Biotech Investing
Lexaria Bioscience (NASDAQ:LEXX)

GLP-1 'Arms Race' Intensifies as the Addressable Markets Continue to Expand

Biotech Investing
Lexaria Bioscience (NASDAQ:LEXX)

GLP-1 "Arms Race" Intensifies as the Addressable Markets Continue to Expand

Biotech Investing
International

Government approvals secured for the use of Galidesivir as a treatment for Bundibugyo Ebola epidemic in Africa

SmartNews
Solvonis Therapeutics (LSE:SVNS)

Expansion of SVN-015 into Depression Following Positive Preclinical Data

Pharmaceutical Investing

Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock

SmartNews
Cardiex Limited (ASX:CDX)

FY25 Preliminary Results Summary and Company Update

Geography
Cardiex Limited (ASX:CDX)

Appendix 4E

Geography
More biotech News
Editors' Picks
Life Science Investing

Biotech and Pharma Market Update: Q1 2026 in Review

Biotech Investing

Biotech Market Forecast: Top Trends for Biotech in 2026

Life Science Investing

Biotech and Pharma Market Update: Q3 2025 in Review

Latest biotech News

More biotech News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES